Year: 2022

Inter&Co, Inc Reports Third Quarter 2022 Financial Results

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

BELO HORIZONTE-MG, Brazil, Nov. 08, 2022 (GLOBE NEWSWIRE) — Inter&Co (NASDAQ: INTR | B3:INBR32), a leading Brazilian Super App offering financial and nonfinancial services, reported today financial results for its third quarter ended September 30, 2022. Financial results are expressed in Brazilian reais and are presented under IFRS (International Financial Reporting Standards). The full earnings release has been made available on the Company’s Investor Relations website at ri.bancointer.com.br/intereco. João Vitor Menin, CEO of Inter&Co. stated: “We concluded another excellent quarter, the first full quarter following our listing on Nasdaq in June. Our culture of innovation has been instrumental in delivering our strong financial performance and continually improving our customer value proposition, including...

3D Systems Reports Third Quarter 2022 Financial Results

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

ROCK HILL, S.C., Nov. 08, 2022 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the third quarter ended September 30, 2022. Third Quarter HighlightsRevenue of $132.3 million decreased (15.3)% compared to Q3 2021; Q3 non-GAAP revenue excluding divestitures and on a constant currency basis(1) increased 2.7%, reflecting solid demand in both the Industrial and Healthcare segments, despite supply chain and macroeconomic challenges and lower sales to certain dental market customers Net loss of $(37.4) million, diluted loss per share of $(0.30), and diluted non-GAAP loss per share(1) of $(0.05) Adjusted EBITDA(1) of $(0.3) million reflects inflationary impacts on input costs and continued investments in growth areas of our business and product portfolio Cash & short-term investments...

Occidental Announces 3rd Quarter 2022 Results

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

HOUSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its third quarter 2022 financial results. The announcement and financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call on Wednesday, November 9, 2022, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10170398/f410bb9e66. A recording of the webcast will be posted on the Investor Relations section of the website after the call is completed. About...

Globus Medical Reports Third Quarter 2022 Results

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

AUDUBON, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2022.Worldwide net sales were $254.1 million, an increase of 10.6%, or 12.6% on a constant currency basis GAAP net income for the quarter was $47.4 million GAAP diluted earnings per share (“EPS”) was $0.47 and non-GAAP diluted EPS was $0.50 Non-GAAP adjusted EBITDA was $82.8 million, or 32.6% of net sales“Our third quarter sales grew 12.6% on a constant currency basis, as we continue to make market share gains by providing industry leading innovative solutions in spine care,” commented Dan Scavilla, President and CEO. “Our U.S. Spine business grew an impressive 9.0%, which is evidence of our ability to hold the share gains we’ve...

HCI Group Reports Third Quarter 2022 Results

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

Claims from Hurricane Ian Remain Consistent with Prior DisclosureGross Premiums Earned Grew 21% Over Last YearThird Quarter Loss Ratio Declined to 41.4% Excluding Ian TAMPA, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), a holding company with operations in homeowners insurance, information technology services, real estate, and reinsurance, reported a net loss of $51.5 million, or $5.66 loss per share, in the third quarter of 2022 compared with net loss of $4.9 million, or $0.72 loss per share, in the third quarter of 2021. Adjusted net loss (a non-GAAP measure which excludes net unrealized gains or losses on equity securities) was $51.2 million, or $5.62 loss per share, in the third quarter of 2022 compared with adjusted net loss of $3.5 million, or $0.64 loss per share, in the third quarter of 2021. This press...

Aterian Reports Third Quarter 2022 Results

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

Reports Third Quarter 2022 Net Revenue of $66.3 Million Targeting Adjusted EBITDA Profitability in the Second Half of 2023 Driven Primarily by Improving International Shipping Rates and Cost Reductions NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2022. Third Quarter 2022 HighlightsThird quarter 2022 net revenue declined 2.6% to $66.3 million, compared to $68.1 million in the third quarter of 2021. Third quarter 2022 gross margin declined to 45.5%, compared to 50.2% in the third quarter of 2021, primarily due to the liquidation of high priced excess inventory. Third quarter 2022 contribution margin declined to 1.1% from 12.1% in the third quarter of 2021, primarily due to the liquidation of high priced excess...

Gulf Island Reports Third Quarter 2022 Results

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

THE WOODLANDS, Texas, Nov. 08, 2022 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced results for the third quarter 2022. THIRD QUARTER 2022 SUMMARY (as compared to the third quarter 2021)Revenue of $39.6 million, 102.1% increase y/y Consolidated income from continuing operations and EBITDA of $0.6 million and $1.9 million, respectively, including loss from Shipyard Division of $1.4 million, non-cash impairment charge of $0.5 million and gain from insurance recoveries of $1.3 million Operating income and EBITDA for Services Division of $2.4 million and $2.8 million, respectively Operating income and EBITDA for Fabrication Division of $2.1 million and $2.9 million, respectively,...

CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

Written by Customer Service on November 8, 2022. Posted in Earnings Releases And Operating Results.

– Advancing wholly owned, next-generation conditionally activated therapeuticsCX-2051 (EpCAM-directed ADC) and CX-801 (Interferon alpha-2b), with INDs anticipated in 2023 – – CX-904, Company’s first clinical stage Probody T-cell bispecific (EFGRxCD3), continues to advance in Phase 1 dose escalation – – Continued progress with Phase 2 collaborator programs CX-2029 (AbbVie, Phase 2) and BMS-986249 (Bristol Myers Squibb, Phase 2) – SOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today reported third quarter 2022 financial results and provided a business update. “CytomX’s progress in the third quarter highlights the potential of our pipeline as well as the breadth and versatility...

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

Written by Customer Service on November 8, 2022. Posted in Mergers And Acquisitions.

Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercialization of neffy® in the U.S., if Approved neffy® NDA Currently Under FDA Review; PDUFA Anticipated Mid-2023 MAA validated in the European Union Under Review SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) (ARS or the Company), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced the closing of its merger with Silverback Therapeutics, Inc. (Silverback). This follows the satisfaction of all customary closing conditions, including approval of the merger by the stockholders of Silverback. The combined company will operate as ARS Pharmaceuticals,...

Yara prices debut US dollar green notes offering

Written by Customer Service on November 8, 2022. Posted in Public Companies.

Oslo, 8 November 2022: Yara International ASA today priced its debut offering of USD 600 million 7.378% Green Notes due 2032 (the “Notes”). The Notes will be issued pursuant to Rule 144A/Regulation S. Yara intends to allocate an amount equivalent to the net proceeds from this offering to finance, or refinance in whole or in part, one or more, new or existing, green investments or assets in accordance with Yara’s green financing framework. Yara’s green financing framework and a second party opinion thereon issued by CICERO Shades of Green are available at Yara’s webpage at the following link: https://www.yara.com/investor-relations/reports-presentations/. The expected ratings of the notes from Moody’s and Standard & Poor’s are Baa2 and BBB, respectively. Contact Nina Kleiv, Head of Finance, Treasury & InsuranceMobile:...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals